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Abstract
Takotsubo cardiomyopathy (TSC) is a transient cardiac condition brought on by physical and emotional distress
causing left ventricular akinesis. Typically, patients are older females that present with substernal chest pain radiating to
the left arm, presenting similarly to acute coronary syndrome. In addition, the elevated troponins and EKG changes such
as ST elevations and T wave inversions seen in acute coronary syndrome may also be appreciated in TSC. While there
have been many reports of TSC presenting in a similar manner to acute coronary syndrome, this case report will describe
an atypical presentation of Takotsubo cardiomyopathy. The patient we are presenting is an African American middleaged female who presented to the emergency department with a four-day history of non-bilious, non-bloody vomiting.
Chief complaint denied any chest pain, shortness of breath, or recent physical and emotional stressors. Her past medical
history was signiﬁcant for Chronic Obstructive Pulmonary Disease Gold Criteria 2, controlled Hypertension, and
Human Immunodeﬁciency Virus for which she is on antiretroviral therapy. Her hospital course was complicated by
shortness of breath beginning on day two as well as elevated troponin levels and global T wave inversions on EKG.
Patient underwent cardiac catheterization, which revealed left ventricular akinesis with an ejection fraction of <30%.
Catherization also revealed no obstructive coronary artery disease, thus the diagnosis of Takotsubo cardiomyopathy was
made.
Keywords: Takotsubo cardiomyopathy, Reversible cardiomyopathy, Stress cardiomyopathy, Left ventricular heart failure,
Atypical takotsubo cardiomyopathy

1. Introduction

T

akotsubo cardiomyopathy (TSC) is a reversible
heart condition caused by increased sympathetic activity. Overtime, mental and physical
stressors weaken the left ventricle, causing apical
ballooning of the left ventricle.
TSC is often mistaken for Acute Coronary Syndrome (ACS) due to similar clinical presentation.
The International Takotsubo Registry reports a
prevalence of 1.2% of TSC cases presenting with
positive troponin. ACS is a manifestation of coronary artery disease (CAD), most commonly caused
by the process of atherosclerosis. According to
American Heart Association, CAD is the leading
cause of death in adults in the United States, accounting for 1/3 of all deaths in subjects over age 35
in 2016. 15.5 million people reported having CAD

over the age of 20 years old in the United States in
2016.1 Of this number, 2% incidence were subsequently diagnosed with TSC due to the absence of
coronary artery obstruction.
There is a ﬁve-fold preponderance in women to
men, with some studies showing an incidence of
10% TSC in women with CAD.2 The most common
presenting chief complaint of patients with TSC is
both dyspnea and chest pain encompassing 64% of
incidence.3 Dyspnea alone occurs with an incidence
of 24%. The chest pain alone is 16% of the time in
the diagnosis of TSC.3
Patients with TSC typically present with dyspnea
and/or angina-like symptoms without atherosclerotic arteries. Here we present an atypical presentation of TSC in which the patient presented initially
with several days of gastrointestinal symptoms. She
was found to have an abnormal EKG with elevated
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troponin, which lead to cardiac catheterization,
conﬁrming the diagnosis TSC.

2. Case
A 57-year-old African American woman with a
past medical history of Chronic Obstructive Pulmonary Disease Gold Criteria 2, controlled Hypertension
on
hydrochlorothiazide,
Human
Immunodeﬁciency Virus on antiretroviral therapy
with a CD4 count of 700 and viral load of 1,200,
peptic ulcer disease, chronic back pain, and tobaccouse disorder presented to the emergency department with a four-day history of non-bilious, nonbloody vomiting, nausea and diarrhea. Over that
time period she reported having 4e5 episodes of
emesis that was accompanied by 3 watery nonbloody episodes of diarrhea. She denied any pain,
fever, chills, SOB, chest pain, and urinary changes.
She attributed the GI symptoms to “food
poisoning”. She took antacids with no relief, and
reported staying hydrated by drinking water and
sports drinks. Later, she remembered experiencing
mild chest pain, which improved. She could not
identify exacerbating or alleviating symptoms.
Initial EKG in the emergency department demonstrated normal sinus rhythm with global T wave
inversions. Repeat labs were signiﬁcant for an initial
troponin of 0.9 (normal values 0.0e0.04), elevated DDimer of 900 (normal values 220e500 ng/mL),
proBNP of 8800 (normal values < 125 pg/mL). CTA
was negative for pulmonary embolism. She was
suspected to have NSTEMI secondary to stress from
vomiting. She was cautiously started on heparin
drip due to her history of GI bleed. On admission,
the patient was hemodynamically stable. On day
two of admission, the patient developed worsened
shortness of breath and sharp, non-radiating, left
sided chest pain under her sternum and left breast
8/10 in severity. She characterized the pain as a
sharp pressure. No exacerbating or alleviating factors. She developed mild tachycardia HR 102; her
vitals otherwise remained stable. The patient was
uncomfortable, but without diaphoresis. Pain was
not reproducible with palpation. She had normal S1
and S2 without murmurs, rubs, or gallops on cardiac
auscultation and bilateral vesicular breath sounds.
She had no peripheral leg edema. Urine toxicology
was positive for fentanyl, methadone, and
cannabinoids.
The patient had several risk factors for CAD that
included hypertension, smoking tobacco, and HIV,
however she was never previously diagnosed with
CAD. The patient reported limited exercise capacity
since the start of the COVID-19 pandemic, for the

past six months. Prior to admission she had experienced mild fatigue and shortness of breath. The
patient reports no other medical complications or
illnesses recently. Due to the T wave changes on the
EKG and mild troponin elevation, an echocardiogram was ordered. Echo revealed left ventricular
ejection fraction of 25e35%, left ventricle apical
hypokinesis and mild apical ballooning suggestive
of distal left anterior descending branch occlusion.
Coronary angiogram procedure was performed to
identify occlusions or stenosis of arteries and was
found to have left ventricular estimated ejection
fraction of <30% with apical akinesis suggestive of
TSC.

3. Discussion
Takotsubo cardiomyopathy (TSC) is a cardiac
condition that resembles acute coronary syndrome
however, in TSC the ventricular (LV) systolic
dysfunction occurs in the absence of coronary artery
stenosis or other causes. Other differential diagnoses that should be considered include vasospastic angina secondary to cocaine use, STelevation myocardial infarction, viral or idiopathic
myocarditis, or pericarditis. While the pathophysiology underlying TSC is not well understood,
postulated mechanisms include catecholamine
excess, dysfunction of the microvasculature, and
multivessel coronary artery spasm. The catecholamine excess from the stressors overtime causes
reversible LV wall dysfunction.
Much of the evidence on TSC diagnosis and
management was published by the International
Takotsubo Registry (InterTAK). InterTAK consists of
26 centers in the United States and Europe and was
established in order to better understand the clinical
features, prognostic predictors and outcomes of
TSC.9 The registry collected data from 2011 through
2014 using the Mayo Clinic Diagnostic criteria for
TSC.
Due to the increasing association of TSC with age,
patients often have concomitant comorbidities that
overlap with CAD.1 In a prospective study by
Schneider Et al. which consisted of 296 female patients and 28 male patients from 37 hospitals, the
mean ages of females and males diagnosed with
TSC were 68 ± 12 vs 66 ± 12 years, respectively.
While this study found that TSC predominantly
occurs in females, the 9% of males included in the
study is comparable to the existing low prevalence
of TSC in the general male population. A notable
difference that is seen between each sex is the
triggering event prior to the onset of TSC. Physical
stress is the more common trigger for males while

emotional or no identiﬁable trigger was linked to
TSC in females.4
While TSC most commonly occurs in postmenopausal women, TSC has also been observed in
women under the age of 50 (5e11% of cases) and
premenopausal women.5 Dr. Sharkey et al. found
35% of the 136 consecutive TSC patients in a prospective cohort study had unique characteristics
that differentiate them from the typical post-menopausal patient group found in TSC. These patients
were either males, had a disease onset at an age less
than 50 years old, a hospital death, recurrent
nonfatal TSC events, had no identiﬁable inciting
event, or had delay in the ejection fraction
normalizing.6
Typically, patients with stress induced cardiomyopathy present with substernal chest pain, syncope,
dyspnea and/or signs and symptoms of congestive
heart disease. These patients typically have elevated
troponins and ST elevations concerning for
myocardial infarctions making ACS a likely cause.1
In a prospective study by Dr. Park et al., 92 of the
3265 patients that presented with non-cardiac
symptoms and did not have a history of cardiac
pathology were found to have left ventricular apical
ballooning on cardiac catheterization consistent
with TSC.7
TSC is often indistinguishable from ACS on the
basis of cardiac enzymes, ECG, and echo ﬁndings.
According to the InterTAK study, anterior precordial lead ST elevations are the most frequent
EKG ﬁnding. Other ﬁndings can include T wave
inversion, QT prolongation, and abnormal Q
waves.8 Additionally, troponin and CK-MB levels
are elevated with a median initial troponin 7.7 times
the upper limit of normal, and CK-MB only mildly
elevated.9 proBNP being elevated. The mainstay for
diagnosis is LV hypokinesis. Cardiac catheterization
in patients with TSC reveals hypokinesis of the LV
wall in 81.7% of cases.10 The LV wall has systolic
apical ballooning resulting in LV systolic dysfunction with a mean ejection fraction of 41%.10
Although TSC is a reversible form of heart failure,
the long-term consequences of the disease can be
severe. In the retrospective study collected from
InterTAK involving 1750 patients, death rate from
any cause is 5.6% per patient-year.9 Additionally,
the rate of major adverse cardiac and cerebrovascular events is 9.9% per patient year. The rate of
recurrence of TSC was 1.8% per patient years with a
span of 25 day up to 9.2 years after the ﬁrst event.
While the disease is more common in women, men
had increased rates of death when compared to
women (12.9% vs 5.0% per patient year, p < 0.001).9
In a large cohort study by Sharkey et al. involving
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136 patients, 85% of patients survived over the
follow up period for 2.9 ± 2 years. Of the 15% of
patients that died after discharge (age 51e92 years)
the causes were noncardiac and most commonly
due to cancer.6 1750 patients from the Takotsubo
Registry were analyzed in a study by Templin et al.
and compared to age and sex matched patients with
ACS. The study found that TSC is associated with an
increased risk for adverse events and females are
more predominantly affected than males.9
In 2004 the Mayo Clinic developed a criterion for
the diagnosis of Takotsubo cardiomyopathy that
was later modiﬁed in 2008.5 A concise criterion of
the disease has been needed to properly distinguish
these patients from other differential diagnoses such
as ACS, myocarditis, and pheochromocytoma. With
the criteria, TSC is becoming more recognizable.
Ideally the criteria are to be used on admission.
Each of the criteria must be met in order to diagnose
TSC and as we learn more about the disease the
criteria will be modiﬁed.5
Mayo Clinic Criterion for the Diagnosis of
Takotsubo Cardiomyopathy:
1. Transient hypokinesis, akinesis or dyskinesia of
the left ventricular mid-segments with or
without apical involvement the regional wall
motion abnormalities extend beyond a single
epicardial vascular distribution; a stressful
trigger is often, but not always present.
2. Absence of obstructive coronary disease or
angiographic evidence of acute plaque rupture.
3. New electrocardiographic abnormalities (either
ST-segment elevation and/or T wave inversion)
or modest elevation in cardiac troponin.
4. Absence
of:
Pheochromocytoma
and
Myocarditis.
Physical triggers are more common than
emotional triggers however a triggering event does
not necessarily exclude the diagnosis of TSC.
Greater than 50% of patients had an acute, former or
chronic neurologic or psychiatric disorder.9
Cardiac histopathologic ﬁndings of patients who
have died from sudden deaths during epilepsy or
subarachnoid hemorrhages resembled patients who
died from TSC. The study also conﬁrms troponin
levels and EKG changes are not sufﬁcient to differentiate between CAD and TSC, therefore coronary
angiography is necessary to differentiate between
the two conditions. The presence of CAD is not an
exclusion criterion for diagnosing TSC.9
While TSC does not involve stenosis of the
affected area, concurrent CAD is a common ﬁnding
in non-dysfunctional areas of the heart.11 Of the 450

CASE REPORT

JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES 2022;12:75e79

78

JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES 2022;12:75e79

CASE REPORT

patients in a multicenter prospective study conducted by Parodi et al. 9.6% of patients had at least
one relevant (>50%) coronary stenosis not supplying the dysfunctional myocardium and 90.4% of
patients had irrelevant stenosis or angiographically
normal coronary arteries.11 The patients that had
relevant stenosis generally were older in age, diabetic, had family history of CAD and had acute
mitral regurgitations.11
TSC is a transient cardiomyopathy, therefore, long
term treatment is not necessary. Removing the
inciting stressor can improve cardiac wall motion.12
Pharmacological management can include beta
blockers, ACE inhibitors and diuretics to improve
LV systolic dysfunction.13 Medication combinations
are similar to that in heart failure with reduced
ejection fraction because of the similar LV
dysfunction. However, as opposed to heart failure,
stress induced cardiomyopathy has a good prognosis and typically patients can recover within
weeks.14
The classic presentation of TSC has been taught as
a devastating emotional stressor causing cardiac
chest pain. More awareness and documentation of
unexpected triggers and atypical symptoms is
needed to better understand the disease. Our review of the literature revealed only a few other cases
in which nausea and/or vomiting were a physical
trigger for or a presenting feature of TSC.6,15,16 It
was unclear whether our patient's gastrointestinal
symptoms were a cause or consequence of TSC, as
she could not recall another emotional stressor.
Perhaps the diversity of triggers leading to TSC is a
testament to personalized nature of disease - the
same emotional trigger or physical illness may seem
benign to one individual and may cause overwhelming stress leading to cardiomyopathy in
another individual. Likewise, the absence of identiﬁable stressor in a large proportion of cases may
suggest that many patients often have hidden
stressors in their lives of which they are unaware,
yet can cause serious health consequences.
During the hospitalization, our patient could not
identify the causal stressor in her life that could
have caused the TSC diagnosis. However, after
discharge, she worked closely with a psychiatrist to
reveal any signiﬁcant work and personal life
stressors that she may be facing. During follow up,
she reported improvement to her level of stress. She
reports feeling better and losing a healthy amount of
weight through exercise and dietary changes. She
did not suffer any further episodes of shortness of
breath or chest pain and follows up with her
outpatient cardiologist regularly. She has taken the
necessary steps to ensure success in her health.

After arriving at the ED with gastrointestinal concerns and discovering TSC as a diagnosis, it was the
motivational trigger that led her to remove the
emotional or physical stressors from her life and
focus on her overall health, mind and body.
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